Jeremy W. Linsley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeremy W. Linsley has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Steven Finkbeiner
Center for Systems and Therapeutics, Gladstone Institutes, San Francisco, CA 94158, USA
7 shared publications - John Y. Kuwada
University of Michigan
6 shared publications Ashkan Javaherian
Gladstone Center for Systems and Therapeutics, San Francisco, USA
5 shared publicationsViral Oza
Gladstone Center for Systems and Therapeutics, San Francisco, USA
4 shared publicationsDrew Linsley
Brown University, Department of Cognitive, Linguistic and Psychological Sciences, Providence, RI 02912, USA
3 shared publications- Eric James Horstick
Affiliations West Virginia University, Department of Biology, Morgantown, West Virginia, United States of America, West Virginia University School of Medicine, Department of Neuroscience, West Virginia University, Morgantown, West Virginia, United States of America
3 shared publications
Latest Publications
- 5 November 2026
- Published by EMBL-EBI
Single-cell live imaging of optogenetic Tau dynamics in APP V717I/V717I iPSC-derived glutamatergic neurons under a drug repurposing screen
BioStudies – one package for all the data supporting a study
- 5 November 2026
- Published by EMBL-EBI
Single-cell live imaging of optogenetic Tau dynamics in APP V717I/V717I iPSC-derived glutamatergic neurons under a drug repurposing screen
BioStudies – one package for all the data supporting a study
- Open Access
- 7 June 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (23) , eadj0385
A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction
Excess gene dosage from chromosome 21 (chr21) causes Down syndrome (DS), spanning developmental and acute phenotypes in terminal cell types. Which phenotypes remain amenable to intervention after development is unknown. To address this question in a model of DS neurogenesis, we derived trisomy 21 (T21) human induced pluripotent stem cells (iPSCs) alongside, otherwise, isogenic euploid controls from mosaic DS fibroblasts and equipped one chr21 copy with an inducible XIST transgene. Monoallelic chr21 silencing by XIST is near-complete and irreversible in iPSCs. Differential expression reveals that T21 neural lineages and iPSCs share suppressed translation and mitochondrial pathways and activate cellular stress responses. When XIST is induced before the neural progenitor stage, T21 dosage correction suppresses a pronounced skew toward astrogenesis in neural differentiation. Because our transgene remains inducible in postmitotic T21 neurons and astrocytes, we demonstrate that XIST efficiently represses genes even after terminal differentiation, which will empower exploration of cell type–specific T21 phenotypes that remain responsive to chr21 dosage.
- 7 June 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (23) , eadj0385
Open AccessA dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction
Excess gene dosage from chromosome 21 (chr21) causes Down syndrome (DS), spanning developmental and acute phenotypes in terminal cell types. Which phenotypes remain amenable to intervention after development is unknown. To address this question in a model of DS neurogenesis, we derived trisomy 21 (T21) human induced pluripotent stem cells (iPSCs) alongside, otherwise, isogenic euploid controls from mosaic DS fibroblasts and equipped one chr21 copy with an inducible XIST transgene. Monoallelic chr21 silencing by XIST is near-complete and irreversible in iPSCs. Differential expression reveals that T21 neural lineages and iPSCs share suppressed translation and mitochondrial pathways and activate cellular stress responses. When XIST is induced before the neural progenitor stage, T21 dosage correction suppresses a pronounced skew toward astrogenesis in neural differentiation. Because our transgene remains inducible in postmitotic T21 neurons and astrocytes, we demonstrate that XIST efficiently represses genes even after terminal differentiation, which will empower exploration of cell type–specific T21 phenotypes that remain responsive to chr21 dosage.
- Open Access
- 31 May 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (7) , 107433
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegeneration
- 31 May 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (7) , 107433
Open AccessThree dimensional and four dimensional live imaging to study mechanisms of progressive neurodegeneration
- Open Access
A deep-learning-based screening platform in aging-relevant human motor neurons to identify therapeutic compounds for amyotrophic lateral sclerosis
Age is the primary risk factor for most neurodegenerative diseases including amyo-trophic lateral sclerosis (ALS). Despite the clear importance of age on the development and progression of ALS, age is rarely considered a factor in cellular or animal models of ALS. The recent advent of direct reprogramming methodologies, whereby somatic cells such as fibroblasts can be converted into neurons while retaining the age signature of the host, has facilitated the study of age-relevant human cells in vitro for the first time. Despite the promise of this technology, age is a complex, multidimensional, and dy-namic phenotype that makes the interpretation of the interplay between age and dis-ease a great challenge. To circumvent these challenges, we developed a screening platform for directly reprogrammed neurons in an age-relevant human cellular model to better model and identify disease-modifying targets and pathways for ALS. This plat-form uses deep learning image analysis to screen compounds for efficacy against ALS-associated cellular phenotypes and efficiently classifies ALS-like phenotypic signatures as well as predicts the age of the original fibroblast donor. Notably, our work identified NCB-0846, a TNIK/MAP4K7 inhibitor, as a novel compound with the ability to revert ALS-like phenotypes. Moreover, we show that chronic dosing of NCB-0846 in the SOD1G93A mouse model of ALS significantly reduced serum neurofilament-L levels. Our findings establish the power of a platform that combines direct reprogramming of human cells and deep learning as a powerful tool for combatting aging and age-related diseases.
Open AccessA deep-learning-based screening platform in aging-relevant human motor neurons to identify therapeutic compounds for amyotrophic lateral sclerosis
Age is the primary risk factor for most neurodegenerative diseases including amyo-trophic lateral sclerosis (ALS). Despite the clear importance of age on the development and progression of ALS, age is rarely considered a factor in cellular or animal models of ALS. The recent advent of direct reprogramming methodologies, whereby somatic cells such as fibroblasts can be converted into neurons while retaining the age signature of the host, has facilitated the study of age-relevant human cells in vitro for the first time. Despite the promise of this technology, age is a complex, multidimensional, and dy-namic phenotype that makes the interpretation of the interplay between age and dis-ease a great challenge. To circumvent these challenges, we developed a screening platform for directly reprogrammed neurons in an age-relevant human cellular model to better model and identify disease-modifying targets and pathways for ALS. This plat-form uses deep learning image analysis to screen compounds for efficacy against ALS-associated cellular phenotypes and efficiently classifies ALS-like phenotypic signatures as well as predicts the age of the original fibroblast donor. Notably, our work identified NCB-0846, a TNIK/MAP4K7 inhibitor, as a novel compound with the ability to revert ALS-like phenotypes. Moreover, we show that chronic dosing of NCB-0846 in the SOD1G93A mouse model of ALS significantly reduced serum neurofilament-L levels. Our findings establish the power of a platform that combines direct reprogramming of human cells and deep learning as a powerful tool for combatting aging and age-related diseases.
- Open Access
A dynamic in vitro model of Down Syndrome neurogenesis with Trisomy 21 gene dosage correction
/SUMMARY: Excess gene dosage from human chromosome 21 (chr21) causes Down syndrome (DS), spanning developmental as well as acute phenotypes in terminal cell types. Which phenotypes remain amenable to intervention after development is unknown. To address this question in a model of DS neurogenesis, we generated trisomy 21 (T21) human induced pluripotent stem cells (hiPSCs) alongside otherwise isogenic euploid controls from mosaic DS fibroblasts, and integrated an inducible XIST transgene on one chr21 copy. Monoallelic chr21 silencing by XIST was near-complete and irreversible in hiPSCs. Differential expression reveals T21 neural lineages and T21 hiPSCs suppress similar translation and mitochondrial pathways, and activate cellular stress responses. When XIST is induced before the neural progenitor stage, T21 dosage correction mitigates a pronounced skew towards astrogenesis in differentiation. Because our transgene remained inducible in post-mitotic T21 neurons and astrocytes, we demonstrate XIST efficiently represses genes even after terminal differentiation, which will empower exploration of cell type-specific T21 phenotypes that remain responsive to chr21 dosage.
Open AccessA dynamic in vitro model of Down Syndrome neurogenesis with Trisomy 21 gene dosage correction
/SUMMARY: Excess gene dosage from human chromosome 21 (chr21) causes Down syndrome (DS), spanning developmental as well as acute phenotypes in terminal cell types. Which phenotypes remain amenable to intervention after development is unknown. To address this question in a model of DS neurogenesis, we generated trisomy 21 (T21) human induced pluripotent stem cells (hiPSCs) alongside otherwise isogenic euploid controls from mosaic DS fibroblasts, and integrated an inducible XIST transgene on one chr21 copy. Monoallelic chr21 silencing by XIST was near-complete and irreversible in hiPSCs. Differential expression reveals T21 neural lineages and T21 hiPSCs suppress similar translation and mitochondrial pathways, and activate cellular stress responses. When XIST is induced before the neural progenitor stage, T21 dosage correction mitigates a pronounced skew towards astrogenesis in differentiation. Because our transgene remained inducible in post-mitotic T21 neurons and astrocytes, we demonstrate XIST efficiently represses genes even after terminal differentiation, which will empower exploration of cell type-specific T21 phenotypes that remain responsive to chr21 dosage.
- Open Access
- 10 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (50)
Superhuman cell death detection with biomarker-optimized neural networks
High-throughput microscopy has outpaced analysis; biomarker-optimized CNNs are a generalizable, fast, and interpretable solution.
- 10 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (50)
Open AccessSuperhuman cell death detection with biomarker-optimized neural networks
High-throughput microscopy has outpaced analysis; biomarker-optimized CNNs are a generalizable, fast, and interpretable solution.
- Open Access
- 6 September 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-14
Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration
Cell death is a critical process that occurs normally in health and disease. However, its study is limited due to available technologies that only detect very late stages in the process or specific death mechanisms. Here, we report the development of a family of fluorescent biosensors called genetically encoded death indicators (GEDIs). GEDIs specifically detect an intracellular Ca2+ level that cells achieve early in the cell death process and that marks a stage at which cells are irreversibly committed to die. The time-resolved nature of a GEDI delineates a binary demarcation of cell life and death in real time, reformulating the definition of cell death. We demonstrate that GEDIs acutely and accurately report death of rodent and human neurons in vitro, and show that GEDIs enable an automated imaging platform for single cell detection of neuronal death in vivo in zebrafish larvae. With a quantitative pseudo-ratiometric signal, GEDIs facilitate high-throughput analysis of cell death in time-lapse imaging analysis, providing the necessary resolution and scale to identify early factors leading to cell death in studies of neurodegeneration.
- 6 September 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-14
Open AccessGenetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration
Cell death is a critical process that occurs normally in health and disease. However, its study is limited due to available technologies that only detect very late stages in the process or specific death mechanisms. Here, we report the development of a family of fluorescent biosensors called genetically encoded death indicators (GEDIs). GEDIs specifically detect an intracellular Ca2+ level that cells achieve early in the cell death process and that marks a stage at which cells are irreversibly committed to die. The time-resolved nature of a GEDI delineates a binary demarcation of cell life and death in real time, reformulating the definition of cell death. We demonstrate that GEDIs acutely and accurately report death of rodent and human neurons in vitro, and show that GEDIs enable an automated imaging platform for single cell detection of neuronal death in vivo in zebrafish larvae. With a quantitative pseudo-ratiometric signal, GEDIs facilitate high-throughput analysis of cell death in time-lapse imaging analysis, providing the necessary resolution and scale to identify early factors leading to cell death in studies of neurodegeneration.
- 9 November 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (47) , 29914-29924
Stac protein regulates release of neuropeptides
Significance: Many neurons release neuropeptides as well as classical neurotransmitters. Neuropeptides often regulate neural circuits controlling behaviors such as emotional behaviors. However, how neuropeptide release is regulated is not well-understood. We identified aDrosophilagene,Dstac, that is similar to a vertebrate gene that regulates voltage-dependent calcium channels in skeletal muscles and found that it is active in muscles and a subset of neurons, including motor neurons. Using live imaging, electrophysiology, and genetic manipulations, we found that Dstac localizes to motor synapses with muscles and regulates the voltage response of calcium channels and the release of neuropeptides. Since Stac proteins are found in neurons in the vertebrate CNS, they may also be regulators of neuropeptide release in the vertebrate brain.
- 9 November 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (47) , 29914-29924
Stac protein regulates release of neuropeptides
Significance: Many neurons release neuropeptides as well as classical neurotransmitters. Neuropeptides often regulate neural circuits controlling behaviors such as emotional behaviors. However, how neuropeptide release is regulated is not well-understood. We identified aDrosophilagene,Dstac, that is similar to a vertebrate gene that regulates voltage-dependent calcium channels in skeletal muscles and found that it is active in muscles and a subset of neurons, including motor neurons. Using live imaging, electrophysiology, and genetic manipulations, we found that Dstac localizes to motor synapses with muscles and regulates the voltage response of calcium channels and the release of neuropeptides. Since Stac proteins are found in neurons in the vertebrate CNS, they may also be regulators of neuropeptide release in the vertebrate brain.
- Open Access
Super-human cell death detection with biomarker-optimized neural networks
Cell death is an essential process in biology that must be accounted for in live microscopy experiments. Nevertheless, cell death is difficult to detect without perturbing experiments with stains, dyes or biosensors that can bias experimental outcomes, lead to inconsistent results, and reduce the number of processes that can be simultaneously labelled. These additional steps also make live microscopy difficult to scale for high-throughput screening because of the cost, labor, and analysis they entail. We address this fundamental limitation of live microscopy with biomarker-optimized convolutional neural networks (BO-CNN): computer vision models trained with a ground truth biosensor that detect live cells with superhuman, 96% accuracy more than 100 times faster than previous methods. Our models learn to identify important morphological characteristics associated with cell vitality without human input or additional perturbations, and to generalize to other imaging modalities and cell types for which they have no specialized training. We demonstrate that we can interpret decisions from BO-CNN models to gain biological insight into the patterns they use to achieve superhuman accuracy. The BO-CNN approach is broadly useful for live microscopy, and affords a powerful new paradigm for advancing the state of high-throughput imaging in a variety of contexts.
Open AccessSuper-human cell death detection with biomarker-optimized neural networks
Cell death is an essential process in biology that must be accounted for in live microscopy experiments. Nevertheless, cell death is difficult to detect without perturbing experiments with stains, dyes or biosensors that can bias experimental outcomes, lead to inconsistent results, and reduce the number of processes that can be simultaneously labelled. These additional steps also make live microscopy difficult to scale for high-throughput screening because of the cost, labor, and analysis they entail. We address this fundamental limitation of live microscopy with biomarker-optimized convolutional neural networks (BO-CNN): computer vision models trained with a ground truth biosensor that detect live cells with superhuman, 96% accuracy more than 100 times faster than previous methods. Our models learn to identify important morphological characteristics associated with cell vitality without human input or additional perturbations, and to generalize to other imaging modalities and cell types for which they have no specialized training. We demonstrate that we can interpret decisions from BO-CNN models to gain biological insight into the patterns they use to achieve superhuman accuracy. The BO-CNN approach is broadly useful for live microscopy, and affords a powerful new paradigm for advancing the state of high-throughput imaging in a variety of contexts.